Page last updated: 2024-09-04

3,7,12-trihydroxycoprostane and Brain Disorders

3,7,12-trihydroxycoprostane has been researched along with Brain Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freese, DK; Hanson, RF1
Björkhem, I; Buchmann, MS; East, C; Grundy, S; Kvittingen, EA; Lie, SO; Skrede, S1

Reviews

1 review(s) available for 3,7,12-trihydroxycoprostane and Brain Disorders

ArticleYear
Neonatal cholestatic syndromes associated with alterations in bile acid synthesis.
    Journal of pediatric gastroenterology and nutrition, 1983, Volume: 2, Issue:2

    Topics: Abnormalities, Multiple; Bile Acids and Salts; Bile Ducts, Intrahepatic; Brain Diseases; Cholestanols; Cholestasis; Genes, Recessive; Hepatomegaly; Humans; Infant, Newborn; Jaundice, Neonatal; Lipid Metabolism, Inborn Errors; Polycystic Kidney Diseases; Syndrome; Xanthomatosis

1983

Other Studies

1 other study(ies) available for 3,7,12-trihydroxycoprostane and Brain Disorders

ArticleYear
Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis.
    The Journal of clinical investigation, 1986, Volume: 78, Issue:3

    Topics: Brain Diseases; Cells, Cultured; Cholestanetriol 26-Monooxygenase; Cholestanols; Female; Fibroblasts; Humans; Hydroxycholesterols; Hydroxylation; Kinetics; Male; Middle Aged; Steroid Hydroxylases; Substrate Specificity; Xanthomatosis

1986